Literature DB >> 12201186

Pattern of diagnostic and therapeutic care of childhood epilepsy in Alexandria, Egypt.

Amal Bassili1, Tarek Omar, Adel Zaki, Moataz Abdel-Fattah, Gianni Tognoni.   

Abstract

OBJECTIVES: To evaluate the quality of care delivered to children with epilepsy and study the predictors of seizure recurrence after initial control.
DESIGN: A cross-sectional study was conducted during 4-month period (1 January to 30 April 1999).
SETTING: Children's hospitals providing out-patient and in-patient services to the majority of children in Alexandria, Egypt. OUTCOME: Seizure recurrence after at least 6 months from anti-epileptic drug (AED) adjustment.
RESULTS: Electroencephalogram was performed in 82.1% of cases, whereas plasma assay was performed in only 7% of cases. AEDs were initiated after the first seizure rather than the first recurrence of seizure. Carbamazepine was the most frequently prescribed drug, followed by valproate, except for generalized absence type, which was mainly managed by valproate. Suboptimal quality of care consisted mainly of poor diagnostic assessment of children with epilepsy, underuse of plasma monitoring for AED levels, unjustified use of oral AEDs during breakthrough fits, and defective health education to the caregivers of children with epilepsy that was manifested by non-compliance with AEDs in 30.1% of cases. The outcome of the current healthcare was a 71.6% recurrence of seizures after initial control. Continuous seizures before treatment, a polytherapy regimen, and non-compliance with management procedures were significant predictors for seizure recurrence.
CONCLUSIONS: More specialized neurological care and health education programs for the caregivers of children with epilepsy are warranted. By exploring the details of medical practice, a foundation is provided upon which to build a quality improvement program, using the parameters in our study as an initial framework.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12201186     DOI: 10.1093/intqhc/14.4.277

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  10 in total

1.  White coat adherence over the first year of therapy in pediatric epilepsy.

Authors:  Avani C Modi; Lisa M Ingerski; Joseph R Rausch; Tracy A Glauser; Dennis Drotar
Journal:  J Pediatr       Date:  2012-05-18       Impact factor: 4.406

2.  Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.

Authors:  Avani C Modi; Shanna M Guilfoyle; Diego A Morita; Tracy A Glauser
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

3.  Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy.

Authors:  Avani C Modi; Joseph R Rausch; Tracy A Glauser
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

4.  Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy.

Authors:  Avani C Modi; Shanna M Guilfoyle; Joseph Rausch
Journal:  J Pediatr Psychol       Date:  2013-04-23

Review 5.  The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies.

Authors:  Caroline K Mbuba; Anthony K Ngugi; Charles R Newton; Julie A Carter
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

6.  An examination of 1-year adherence and persistence rates to antiepileptic medication in children with newly diagnosed epilepsy.

Authors:  Brandon S Aylward; Joseph R Rausch; Avani C Modi
Journal:  J Pediatr Psychol       Date:  2014-03-19

7.  Health care utilization and outpatient, out-of-pocket costs for active convulsive epilepsy in rural northeastern South Africa: a cross-sectional Survey.

Authors:  Ryan G Wagner; Melanie Y Bertram; F Xavier Gómez-Olivé; Stephen M Tollman; Lars Lindholm; Charles R Newton; Karen J Hofman
Journal:  BMC Health Serv Res       Date:  2016-06-28       Impact factor: 2.655

8.  [Therapeutic drug monitoring of three antiepileptic drugs - Back on twenty years of experience].

Authors:  Samira Serragui; Fatima Zalagh; Driss Soussi Tanani; Lahcen Ouammi; Latifa Ait Moussa; Narjis Badrane; Rachida Soulaymani Bencheikh
Journal:  Pan Afr Med J       Date:  2016-09-19

Review 9.  Defining pediatric polypharmacy: A scoping review.

Authors:  Paul M Bakaki; Alexis Horace; Neal Dawson; Almut Winterstein; Jennifer Waldron; Jennifer Staley; Elia M Pestana Knight; Sharon B Meropol; Rujia Liu; Hannah Johnson; Negar Golchin; James A Feinstein; Shari D Bolen; Lawrence C Kleinman
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

10.  A transdisciplinary team approach to scoping reviews: the case of pediatric polypharmacy.

Authors:  Paul M Bakaki; Jennifer Staley; Rujia Liu; Neal Dawson; Negar Golchin; Alexis Horace; Hannah Johnson; Jennifer Waldron; Almut Winterstein; Lawrence C Kleinman; Shari D Bolen
Journal:  BMC Med Res Methodol       Date:  2018-10-04       Impact factor: 4.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.